Flooding and Communicable Diseases Fact Sheet
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Balantidium Coli
GLOBAL WATER PATHOGEN PROJECT PART THREE. SPECIFIC EXCRETED PATHOGENS: ENVIRONMENTAL AND EPIDEMIOLOGY ASPECTS BALANTIDIUM COLI Francisco Ponce-Gordo Complutense University Madrid, Spain Kateřina Jirků-Pomajbíková Institute of Parasitology Biology Centre, ASCR, v.v.i. Budweis, Czech Republic Copyright: This publication is available in Open Access under the Attribution-ShareAlike 3.0 IGO (CC-BY-SA 3.0 IGO) license (http://creativecommons.org/licenses/by-sa/3.0/igo). By using the content of this publication, the users accept to be bound by the terms of use of the UNESCO Open Access Repository (http://www.unesco.org/openaccess/terms-use-ccbysa-en). Disclaimer: The designations employed and the presentation of material throughout this publication do not imply the expression of any opinion whatsoever on the part of UNESCO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The ideas and opinions expressed in this publication are those of the authors; they are not necessarily those of UNESCO and do not commit the Organization. Citation: Ponce-Gordo, F., Jirků-Pomajbíková, K. 2017. Balantidium coli. In: J.B. Rose and B. Jiménez-Cisneros, (eds) Global Water Pathogens Project. http://www.waterpathogens.org (R. Fayer and W. Jakubowski, (eds) Part 3 Protists) http://www.waterpathogens.org/book/balantidium-coli Michigan State University, E. Lansing, MI, UNESCO. Acknowledgements: K.R.L. Young, Project Design editor; Website Design (http://www.agroknow.com) Published: January 15, 2015, 11:50 am, Updated: October 18, 2017, 5:43 pm Balantidium coli Summary 1.1.1 Global distribution Balantidium coli is reported worldwide although it is To date, Balantidium coli is the only ciliate protozoan more common in temperate and tropical regions (Areán and reported to infect the gastrointestinal track of humans. -
Globalization and Infectious Diseases: a Review of the Linkages
TDR/STR/SEB/ST/04.2 SPECIAL TOPICS NO.3 Globalization and infectious diseases: A review of the linkages Social, Economic and Behavioural (SEB) Research UNICEF/UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR) The "Special Topics in Social, Economic and Behavioural (SEB) Research" series are peer-reviewed publications commissioned by the TDR Steering Committee for Social, Economic and Behavioural Research. For further information please contact: Dr Johannes Sommerfeld Manager Steering Committee for Social, Economic and Behavioural Research (SEB) UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) World Health Organization 20, Avenue Appia CH-1211 Geneva 27 Switzerland E-mail: [email protected] TDR/STR/SEB/ST/04.2 Globalization and infectious diseases: A review of the linkages Lance Saker,1 MSc MRCP Kelley Lee,1 MPA, MA, D.Phil. Barbara Cannito,1 MSc Anna Gilmore,2 MBBS, DTM&H, MSc, MFPHM Diarmid Campbell-Lendrum,1 D.Phil. 1 Centre on Global Change and Health London School of Hygiene & Tropical Medicine Keppel Street, London WC1E 7HT, UK 2 European Centre on Health of Societies in Transition (ECOHOST) London School of Hygiene & Tropical Medicine Keppel Street, London WC1E 7HT, UK TDR/STR/SEB/ST/04.2 Copyright © World Health Organization on behalf of the Special Programme for Research and Training in Tropical Diseases 2004 All rights reserved. The use of content from this health information product for all non-commercial education, training and information purposes is encouraged, including translation, quotation and reproduction, in any medium, but the content must not be changed and full acknowledgement of the source must be clearly stated. -
On Confinement and Quarantine Concerns on an SEIAR Epidemic
S S symmetry Article On Confinement and Quarantine Concerns on an SEIAR Epidemic Model with Simulated Parameterizations for the COVID-19 Pandemic Manuel De la Sen 1,* , Asier Ibeas 2 and Ravi P. Agarwal 3 1 Campus of Leioa, Institute of Research and Development of Processes IIDP, University of the Basque Country, 48940 Leioa (Bizkaia), Spain 2 Department of Telecommunications and Systems Engineering, Universitat Autònoma de Barcelona, UAB, 08193 Barcelona, Spain; [email protected] 3 Department of Mathematics, Texas A & M University, 700 Univ Blvd, Kingsville, TX 78363, USA; [email protected] * Correspondence: [email protected] Received: 7 September 2020; Accepted: 30 September 2020; Published: 7 October 2020 Abstract: This paper firstly studies an SIR (susceptible-infectious-recovered) epidemic model without demography and with no disease mortality under both total and under partial quarantine of the susceptible subpopulation or of both the susceptible and the infectious ones in order to satisfy the hospital availability requirements on bed disposal and other necessary treatment means for the seriously infectious subpopulations. The seriously infectious individuals are assumed to be a part of the total infectious being described by a time-varying proportional function. A time-varying upper-bound of those seriously infected individuals has to be satisfied as objective by either a total confinement or partial quarantine intervention of the susceptible subpopulation. Afterwards, a new extended SEIR (susceptible-exposed-infectious-recovered) epidemic model, which is referred to as an SEIAR (susceptible-exposed-symptomatic infectious-asymptomatic infectious-recovered) epidemic model with demography and disease mortality is given and focused on so as to extend the above developed ideas on the SIR model. -
The Intestinal Protozoa
The Intestinal Protozoa A. Introduction 1. The Phylum Protozoa is classified into four major subdivisions according to the methods of locomotion and reproduction. a. The amoebae (Superclass Sarcodina, Class Rhizopodea move by means of pseudopodia and reproduce exclusively by asexual binary division. b. The flagellates (Superclass Mastigophora, Class Zoomasitgophorea) typically move by long, whiplike flagella and reproduce by binary fission. c. The ciliates (Subphylum Ciliophora, Class Ciliata) are propelled by rows of cilia that beat with a synchronized wavelike motion. d. The sporozoans (Subphylum Sporozoa) lack specialized organelles of motility but have a unique type of life cycle, alternating between sexual and asexual reproductive cycles (alternation of generations). e. Number of species - there are about 45,000 protozoan species; around 8000 are parasitic, and around 25 species are important to humans. 2. Diagnosis - must learn to differentiate between the harmless and the medically important. This is most often based upon the morphology of respective organisms. 3. Transmission - mostly person-to-person, via fecal-oral route; fecally contaminated food or water important (organisms remain viable for around 30 days in cool moist environment with few bacteria; other means of transmission include sexual, insects, animals (zoonoses). B. Structures 1. trophozoite - the motile vegetative stage; multiplies via binary fission; colonizes host. 2. cyst - the inactive, non-motile, infective stage; survives the environment due to the presence of a cyst wall. 3. nuclear structure - important in the identification of organisms and species differentiation. 4. diagnostic features a. size - helpful in identifying organisms; must have calibrated objectives on the microscope in order to measure accurately. -
Optimal Vaccine Subsidies for Endemic and Epidemic Diseases Matthew Goodkin-Gold, Michael Kremer, Christopher M
WORKING PAPER · NO. 2020-162 Optimal Vaccine Subsidies for Endemic and Epidemic Diseases Matthew Goodkin-Gold, Michael Kremer, Christopher M. Snyder, and Heidi L. Williams NOVEMBER 2020 5757 S. University Ave. Chicago, IL 60637 Main: 773.702.5599 bfi.uchicago.edu OPTIMAL VACCINE SUBSIDIES FOR ENDEMIC AND EPIDEMIC DISEASES Matthew Goodkin-Gold Michael Kremer Christopher M. Snyder Heidi L. Williams The authors are grateful for helpful comments from Witold Więcek and seminar participants in the Harvard Economics Department, Yale School of Medicine, the “Infectious Diseases in Poor Countries and the Social Sciences” conference at Cornell University, the DIMACS “Game Theoretic Approaches to Epidemiology and Ecology” workshop at Rutgers University, the “Economics of the Pharmaceutical Industry” roundtable at the Federal Trade Commission’s Bureau of Economics, the U.S. National Institutes of Health “Models of Infectious Disease Agent” study group at the Hutchinson Cancer Research Center in Seattle, the American Economic Association “Economics of Infectious Disease” session, and the Health and Pandemics (HELP!) Economics Working Group “Covid-19 and Vaccines” workshop. Maya Durvasula, Nishi Jain, Amrita Misha, Frank Schilbach, and Alfian Tjandra provided excellent research assistance. Williams gratefully acknowledges financial support from NIA grant number T32- AG000186 to the NBER. © 2020 by Matthew Goodkin-Gold, Michael Kremer, Christopher M. Snyder, and Heidi L. Williams. All rights reserved. Short sections of text, not to exceed two paragraphs, may be quoted without explicit permission provided that full credit, including © notice, is given to the source. Optimal Vaccine Subsidies for Endemic and Epidemic Diseases Matthew Goodkin-Gold, Michael Kremer, Christopher M. Snyder, and Heidi L. -
A New Twenty-First Century Science for Effective Epidemic Response
Review A new twenty-first century science for effective epidemic response https://doi.org/10.1038/s41586-019-1717-y Juliet Bedford1, Jeremy Farrar2*, Chikwe Ihekweazu3, Gagandeep Kang4, Marion Koopmans5 & John Nkengasong6 Received: 10 June 2019 Accepted: 24 September 2019 With rapidly changing ecology, urbanization, climate change, increased travel and Published online: 6 November 2019 fragile public health systems, epidemics will become more frequent, more complex and harder to prevent and contain. Here we argue that our concept of epidemics must evolve from crisis response during discrete outbreaks to an integrated cycle of preparation, response and recovery. This is an opportunity to combine knowledge and skills from all over the world—especially at-risk and afected communities. Many disciplines need to be integrated, including not only epidemiology but also social sciences, research and development, diplomacy, logistics and crisis management. This requires a new approach to training tomorrow’s leaders in epidemic prevention and response. connected, high-density urban areas (particularly relevant to Ebola, Anniversary dengue, influenza and severe acute respiratory syndrome-related coro- collection: navirus SARS-CoV). These factors and effects combine and interact, go.nature.com/ fuelling more-complex epidemics. nature150 Although rare compared to those diseases that cause the majority of the burden on population health, the nature of such epidemics disrupts health systems, amplifies mistrust among communities and creates high and long-lasting socioeconomic effects, especially in low- and When Nature published its first issue in 18691, a new understanding of middle-income countries. Their increasing frequency demands atten- infectious diseases was taking shape. The work of William Farr2, Ignaz tion. -
SNF Mobility Model: ICD-10 HCC Crosswalk, V. 3.0.1
The mapping below corresponds to NQF #2634 and NQF #2636. HCC # ICD-10 Code ICD-10 Code Category This is a filter ceThis is a filter cellThis is a filter cell 3 A0101 Typhoid meningitis 3 A0221 Salmonella meningitis 3 A066 Amebic brain abscess 3 A170 Tuberculous meningitis 3 A171 Meningeal tuberculoma 3 A1781 Tuberculoma of brain and spinal cord 3 A1782 Tuberculous meningoencephalitis 3 A1783 Tuberculous neuritis 3 A1789 Other tuberculosis of nervous system 3 A179 Tuberculosis of nervous system, unspecified 3 A203 Plague meningitis 3 A2781 Aseptic meningitis in leptospirosis 3 A3211 Listerial meningitis 3 A3212 Listerial meningoencephalitis 3 A34 Obstetrical tetanus 3 A35 Other tetanus 3 A390 Meningococcal meningitis 3 A3981 Meningococcal encephalitis 3 A4281 Actinomycotic meningitis 3 A4282 Actinomycotic encephalitis 3 A5040 Late congenital neurosyphilis, unspecified 3 A5041 Late congenital syphilitic meningitis 3 A5042 Late congenital syphilitic encephalitis 3 A5043 Late congenital syphilitic polyneuropathy 3 A5044 Late congenital syphilitic optic nerve atrophy 3 A5045 Juvenile general paresis 3 A5049 Other late congenital neurosyphilis 3 A5141 Secondary syphilitic meningitis 3 A5210 Symptomatic neurosyphilis, unspecified 3 A5211 Tabes dorsalis 3 A5212 Other cerebrospinal syphilis 3 A5213 Late syphilitic meningitis 3 A5214 Late syphilitic encephalitis 3 A5215 Late syphilitic neuropathy 3 A5216 Charcot's arthropathy (tabetic) 3 A5217 General paresis 3 A5219 Other symptomatic neurosyphilis 3 A522 Asymptomatic neurosyphilis 3 A523 Neurosyphilis, -
Enteric Protozoa in the Developed World: a Public Health Perspective
Enteric Protozoa in the Developed World: a Public Health Perspective Stephanie M. Fletcher,a Damien Stark,b,c John Harkness,b,c and John Ellisa,b The ithree Institute, University of Technology Sydney, Sydney, NSW, Australiaa; School of Medical and Molecular Biosciences, University of Technology Sydney, Sydney, NSW, Australiab; and St. Vincent’s Hospital, Sydney, Division of Microbiology, SydPath, Darlinghurst, NSW, Australiac INTRODUCTION ............................................................................................................................................420 Distribution in Developed Countries .....................................................................................................................421 EPIDEMIOLOGY, DIAGNOSIS, AND TREATMENT ..........................................................................................................421 Cryptosporidium Species..................................................................................................................................421 Dientamoeba fragilis ......................................................................................................................................427 Entamoeba Species.......................................................................................................................................427 Giardia intestinalis.........................................................................................................................................429 Cyclospora cayetanensis...................................................................................................................................430 -
Chapter 2 Disease and Disease Transmission
DISEASE AND DISEASE TRANSMISSION Chapter 2 Disease and disease transmission An enormous variety of organisms exist, including some which can survive and even develop in the body of people or animals. If the organism can cause infection, it is an infectious agent. In this manual infectious agents which cause infection and illness are called pathogens. Diseases caused by pathogens, or the toxins they produce, are communicable or infectious diseases (45). In this manual these will be called disease and infection. This chapter presents the transmission cycle of disease with its different elements, and categorises the different infections related to WES. 2.1 Introduction to the transmission cycle of disease To be able to persist or live on, pathogens must be able to leave an infected host, survive transmission in the environment, enter a susceptible person or animal, and develop and/or multiply in the newly infected host. The transmission of pathogens from current to future host follows a repeating cycle. This cycle can be simple, with a direct transmission from current to future host, or complex, where transmission occurs through (multiple) intermediate hosts or vectors. This cycle is called the transmission cycle of disease, or transmission cycle. The transmission cycle has different elements: The pathogen: the organism causing the infection The host: the infected person or animal ‘carrying’ the pathogen The exit: the method the pathogen uses to leave the body of the host Transmission: how the pathogen is transferred from host to susceptible person or animal, which can include developmental stages in the environment, in intermediate hosts, or in vectors 7 CONTROLLING AND PREVENTING DISEASE The environment: the environment in which transmission of the pathogen takes place. -
Epidemiological Characteristics of COVID-19 Ongoing Epidemic in Iraq
Epidemiological Characteristics of COVID-19 Ongoing Epidemic in Iraq Abdul-Basset A. Al-Hussein , Fadihl Rahma Tahir1 ∗ Department of Electrical Engineering, University of Basrah, Basrah, Iraq *Corresponding author: Abdul-Basset A. Al-Hussein Email address: [email protected]; [email protected] 1 [email protected] (Submitted: 3 April 2020 – Published online: 6 April 2020) DISCLAIMER This paper was submitted to the Bulletin of the World Health Organization and was posted to the COVID-19 open site, according to the protocol for public health emergencies for international concern as described in Vasee Moorthy et al. (http://dx.doi.org/10.2471/BLT.20.251561). The information herein is available for unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited as indicated by the Creative Commons Attribution 3.0 Intergovernmental Organizations licence (CC BY IGO 3.0). RECOMMENDED CITATION Al-Hussein ABA & Tahir FR. Epidemiological Characteristics of COVID-19 Ongoing Epidemic in Iraq. [Preprint]. Bull World Health Organ. E-pub: 6 April 2020. doi: http://dx.doi.org/10.2471/BLT.20.257907 ABSTRACT Summary Epidemic models have been widely used in different forms for studying and forecasting epidemiological processes such as the spread of HIV, SARS, and influenza, and recently, the 2019–20 coronavirus which is an ongoing pandemic of coronavirus disease 2019 (COVID-19), that caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). To find the epidemic tendency and the main metrics of the outbreak of COVID-19 in Iraq. Method We considered a generalized SEIR model to simulate the ongoing spread of the disease and forecast the future behavior of the outbreak. -
Chlamydia, Gonorrhea, and Syphilis
CDC FACT SHEET Reported STDs in the United States, 2019 Sexually transmitted diseases (STDs) are a substantial health challenge facing the United States, and the epidemic disproportionately affects certain populations. Many cases of chlamydia, gonorrhea, and syphilis continue to go undiagnosed and unreported, and data on several other STDs, such as human papillomavirus and herpes simplex virus, are not routinely reported to CDC. As a result, national surveillance data only captures a fraction of America’s STD epidemic. CDC’s STD Surveillance Report provides important insight into the scope, distribution, and trends in STD diagnoses in the country. Strong public health infrastructure is critical to prevent and control STDs, especially among the most vulnerable groups. RECORD HIGH STDS THREATEN STD PREVENTION MILLIONS OF AMERICANS CHALLENGES Maintaining and strengthening core prevention infrastructure is essential to mounting 2,554,908 an effective national response. LIMITED RESOURCES make COMBINED CASES it challenging to quickly identify and treat STDs. State and local reductions in STD screening, treatment, prevention, REPORTED IN 2019 and partner services have resulted in staff layoffs, reduced clinic hours, and increased patient co-pays that can limit access to essential diagnosis and treatment services. Chlamydia Antibiotics can cure 1,808,703 cases chlamydia, gonorrhea, 553 per 100,000 people and syphilis. However, LEFT UNTREATED, these STDs put people, including Gonorrhea infants, at risk for severe, lifelong health outcomes like chronic pain, 616,392 cases reproductive health complications, 188 per 100,000 people and HIV. People who CANNOT Sy philis (all stages) GET STD CARE remain vulnerable to short- 129,813 cases 40 per 100,000 people and long-term health consequences and are Syphilis (primary and secondary) Syphilis (congenital) more likely to transmit infections 38,992 cases 1,870 cases to others—further compounding 1 2 per 100,000 people 49 per 100,000 live births America’s STD burden. -
SARS-Cov-2 and the Role of Orofecal Transmission: Systematic Review Heneghan C, Spencer EA, Brassey J, Jefferson T
medRxiv preprint doi: https://doi.org/10.1101/2020.08.04.20168054; this version posted August 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . SARS-CoV-2 and the Role of Orofecal Transmission In: Analysis of the Transmission Dynamics of COVID-19: An Open Evidence Review. SARS-CoV-2 and the Role of Orofecal Transmission: Systematic Review Heneghan C, Spencer EA, Brassey J, Jefferson T Correspondence [email protected] [email protected] Abstract: 235 Word count 4,168 Abstract Background How SARS-CoV-2 is transmitted is of key public health importance. SARS-CoV-2 has been detected in the feces of some Covid-19 patients which suggests the possibility that the virus could additionally be transmitted via the orofecal route. Methods This review is part of an Open Evidence Review on Transmission Dynamics of Covid-19. We conduct ongoing searches using LitCovid, medRxiv, Google Scholar and Google for Covid-19; assess study quality based on five criteria and report important findings on an ongoing basis. Where necessary authors are contacted for further details or clarification on the content of their articles. Results We found 59 studies: nine reviews and 51 primary studies or reports (one cohort study also included a review) examining the potential role of orofecal transmission of SARS-CoV-2. Half (n=29) were done in China.